Unique Ingredient Identifier 368GB5141J is listed as a ingredient substance
| RN | 151-21-3 |
| EC | 205-788-1 |
| NCIT | C76733 |
| RXCUI | 9871 |
| PUBCHEM | 3423265 |
| MF | C12H25O4S.Na |
| INCHI KEY | DBMJMQXJHONAFJ-UHFFFAOYSA-M |
| SMILES | [Na+].CCCCCCCCCCCCOS([O-])(=O)=O |
UNII 368GB5141J SODIUM LAURYL SULFATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | TABLET | 5.18 MG |
| BUCCAL | TABLET, EXTENDED RELEASE | 5.18 MG |
| BUCCAL/SUBLINGUAL | TABLET | 1.1 MG |
| DENTAL | GEL | 1.47 % |
| DENTAL | PASTE | NA |
| INHALATION | POWDER | NA |
| ORAL | CAPSULE | 25.8 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 3.6 MG |
| ORAL | CAPSULE, DELAYED ACTION | 5.98 MG |
| ORAL | CAPSULE, DELAYED ACTION, COATED | 1 mg |
| ORAL | CAPSULE, DELAYED ACTION, COATED, HARD GELATIN | 2 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 1 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 0.6 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 16.67 MG |
| ORAL | CAPSULE, HARD GELATIN | 16.2 MG |
| ORAL | CAPSULE, SOFT GELATIN | 96 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 9.47 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 3.75 MG |
| ORAL | DISPERSIBLE TABLET | 48 MG |
| ORAL | DROPS | NA |
| ORAL | GRANULE | 6.2 mg |
| ORAL | PELLET | 0.264 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 0.48 MG/5ML |
| ORAL | POWDER, FOR SUSPENSION | 3.3 MG/5ML |
| ORAL | SUSPENSION | 1.5 MG/1ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 0.02 MG/1ML |
| ORAL | TABLET | 51.69 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 1 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 4.8 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 5 MG |
| ORAL | TABLET, CHEWABLE | 2 MG |
| ORAL | TABLET, COATED | 5.2 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 0.48 mg |
| ORAL | TABLET, DELAYED ACTION | 4 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 8.09 MG |
| ORAL | TABLET, DELAYED RELEASE | 3 MG |
| ORAL | TABLET, EXTENDED RELEASE | 51.69 MG |
| ORAL | TABLET, FILM COATED | 20 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 0.8 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 2 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 0.5 mg |
| ORAL | TABLET, SUSTAINED ACTION | 20.62 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 10.5 MG |
| SUBLINGUAL | TABLET | 0.02 MG |
| TOPICAL | CREAM | 0.75 %W/W |
| TOPICAL | CREAM | 0.1 %W/W |
| TOPICAL | EMULSION, CREAM | 2.5 %W/W |
| TOPICAL | GEL | 0.05 %W/W |
| TOPICAL | LOTION | 0.5 %W/W |
| TOPICAL | OINTMENT | 1 %W/W |
| TOPICAL | SHAMPOO | NA |
| TOPICAL | SHAMPOO, SUSPENSION | 40 %W/V |
| TOPICAL | SPONGE | NA |
| TOPICAL | SPRAY | 0.1 %W/W |
| TOPICAL | SPRAY | 0.08 %W/V |
| VAGINAL | CREAM | 0.3 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.3 %W/W |
| VAGINAL | EMULSION, CREAM | 0.33 %W/W |
| VAGINAL | INSERT | 5 MG |
| VAGINAL | TABLET | 5 MG |